Trial · NCT02060721
Adverse events105
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 105
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Macitentan 10 Milligrams (mg) | 10 | 76 | 11 |
| other | Cardiac Failure | Cardiac disorders | Macitentan 10 Milligrams (mg) | 5 | 76 | 5 |
| other | Cataract | Eye disorders | Macitentan 10 Milligrams (mg) | 6 | 76 | 7 |
| other | Diarrhoea | Gastrointestinal disorders | Macitentan 10 Milligrams (mg) | 7 | 76 | 11 |
| other | Oedema Peripheral | General disorders | Macitentan 10 Milligrams (mg) | 11 | 76 | 13 |
| other | Pyrexia | General disorders | Macitentan 10 Milligrams (mg) | 4 | 76 | 5 |
| other | Bronchitis | Infections and infestations | Macitentan 10 Milligrams (mg) | 9 | 76 | 14 |
| other | Covid-19 | Infections and infestations | Macitentan 10 Milligrams (mg) | 6 | 76 | 7 |
| other | Nasopharyngitis | Infections and infestations | Macitentan 10 Milligrams (mg) | 9 | 76 | 15 |
| other | Respiratory Tract Infection Viral | Infections and infestations | Macitentan 10 Milligrams (mg) | 4 | 76 | 4 |
| other | Upper Respiratory Tract Infection | Infections and infestations | Macitentan 10 Milligrams (mg) | 12 | 76 | 21 |
| other | Urinary Tract Infection | Infections and infestations | Macitentan 10 Milligrams (mg) | 7 | 76 | 14 |
| other | Blood Bilirubin Increased | Investigations | Macitentan 10 Milligrams (mg) | 5 | 76 | 6 |
| other | Blood Creatinine Increased | Investigations | Macitentan 10 Milligrams (mg) | 4 | 76 | 4 |
| other | C-Reactive Protein Increased | Investigations | Macitentan 10 Milligrams (mg) | 6 | 76 | 6 |
| other | Haemoglobin Decreased | Investigations | Macitentan 10 Milligrams (mg) | 13 | 76 | 17 |
| other | Weight Decreased | Investigations | Macitentan 10 Milligrams (mg) | 7 | 76 | 8 |
| other | Hyperuricaemia | Metabolism and nutrition disorders | Macitentan 10 Milligrams (mg) | 4 | 76 | 4 |
| other | Hypokalaemia | Metabolism and nutrition disorders | Macitentan 10 Milligrams (mg) | 4 | 76 | 8 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Macitentan 10 Milligrams (mg) | 6 | 76 | 9 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02060721/events